NSPXD

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 6/07/2016
Contact Info
  • 2511 N Loop 1604 W
  • Suite 204
  • San Antonio, TX 78258

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001421204
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. 2003
Employees 1 a/o Dec 31, 2014
Company Officers/Contacts
Christopher Lowe CEO, President
Russell B. Richerson COO
Ronald Shazer Chief Med. Officer, Senior VP
Company Directors
Peter E. Grebow Chairman
Richard E. Buller
Bo Jesper Hansen
Christopher Lowe
Scott V. Ogilvie
Claire M. Thom
Company Notes
  • Formerly=GenSpera, Inc. until 8-2016
Service Providers
Accounting/Auditing Firm
Liggett & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States

Legal Counsel
Silvestre Law Group, P.C.
31200 Via Colinas
Suite 200
Westlake Village, CA, 91362
United States

Investor Relations Firm
LHA
2121 Avenue of the Stars
Suite 2970
Los Angeles, CA, 90067
United States

NSPXD Security Details
Share Structure
Market Value1 $2,110,535 a/o Dec 05, 2016
Authorized Shares 150,000,000 a/o Sep 30, 2016
Outstanding Shares 1,397,705 a/o Nov 18, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders
Shareholders of Record 135 a/o Mar 30, 2016
Short Selling Data
Short Interest 8,511 (38.28%)
Oct 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security